Skip to main content
SpringerLink
Log in

Tumor-Infiltrating CD1a+ DCs and CD8+/FoxP3+ Ratios Served as Predictors for Clinical Outcomes in Tongue Squamous Cell Carcinoma Patients

  • Original Article
  • Published:
Pathology & Oncology Research

Abstract

Tumor-infiltrating immune cells engage in an extensive crosstalk with tumors and act as two-edged swords by inhibiting or promoting cancer growth. Therefore, identifying the density and prognostic values of tumor-infiltrating immune cells will provide valuable tips for cancer treatments. In this study, we identified the density of tumor inflammatory infiltrates and the number of tumor-infiltrating immune cells, including CD3+, CD4+, CD8+, FoxP3+ T cells and CD1a+ dendritic cells (DCs) in 153 tongue squamous cell carcinomas (TSCC). High inflammatory cell infiltration was associated with better overall survival (OS) and disease free survival (DFS). Moreover, the number of CD3+, CD4+, FoxP3+ and CD1a+ cells were associated with tumor differentiation (P<0.001) and the number of FoxP3+, CD1a+ cells and CD8+/FoxP3+ ratios were also associated with tumor stage (P<0.01, P<0.01, P<0.05). In addition, patients with higher CD1a+ DCs had better OS and increased CD8+/FoxP3+ ratios were associated with improved OS and DFS (P = 0.037; P = 0.047; P = 0.033). In conclusion, our results indicated that tumor-infiltrating CD1a+ DCs and CD8+/FoxP3+ ratios were associated with favorable clinical outcomes but not independent prognostic factors for TSCC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bello IO, Soini Y, Salo T (2010) Prognostic evaluation of oral tongue cancer: means, markers and perspectives (I). Oral Oncol 46(9):630–635. https://doi.org/10.1016/j.oraloncology.2010.06.006

    Article  PubMed  Google Scholar 

  2. Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science (New York, NY) 331(6024):1565–1570. https://doi.org/10.1126/science.1203486

    Article  CAS  Google Scholar 

  3. Mao Y, Qu Q, Chen X, Huang O, Wu J, Shen K (2016) The prognostic value of tumor-infiltrating lymphocytes in breast Cancer: a systematic review and meta-analysis. PLoS One 11(4):e0152500. https://doi.org/10.1371/journal.pone.0152500

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Hwang WT, Adams SF, Tahirovic E, Hagemann IS, Coukos G (2012) Prognostic significance of tumor-infiltrating T cells in ovarian cancer: a meta-analysis. Gynecol Oncol 124(2):192–198. https://doi.org/10.1016/j.ygyno.2011.09.039

    Article  PubMed  Google Scholar 

  5. Fang J, Li X, Ma D, Liu X, Chen Y, Wang Y, Lui VWY, Xia J, Cheng B, Wang Z (2017) Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma. BMC Cancer 17(1):375. https://doi.org/10.1186/s12885-017-3317-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Geng Y, Shao Y, He W, Hu W, Xu Y, Chen J, Wu C, Jiang J (2015) Prognostic role of tumor-infiltrating lymphocytes in lung Cancer: a meta-analysis. Cell Physiol Biochem 37(4):1560–1571. https://doi.org/10.1159/000438523

    Article  CAS  PubMed  Google Scholar 

  7. Barnes TA, Amir E (2017) HYPE or HOPE: the prognostic value of infiltrating immune cells in cancer. Br J Cancer 117(4):451–460. https://doi.org/10.1038/bjc.2017.220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Liotta F, Gacci M, Frosali F, Querci V, Vittori G, Lapini A, Santarlasci V, Serni S, Cosmi L, Maggi L, Angeli R, Mazzinghi B, Romagnani P, Maggi E, Carini M, Romagnani S, Annunziato F (2011) Frequency of regulatory T cells in peripheral blood and in tumour-infiltrating lymphocytes correlates with poor prognosis in renal cell carcinoma. BJU Int 107(9):1500–1506. https://doi.org/10.1111/j.1464-410X.2010.09555.x

    Article  CAS  PubMed  Google Scholar 

  9. Ugel S, De Sanctis F, Mandruzzato S, Bronte V (2015) Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages. J Clin Invest 125(9):3365–3376. https://doi.org/10.1172/JCI80006

    Article  PubMed  PubMed Central  Google Scholar 

  10. Wallis SP, Stafford ND, Greenman J (2015) Clinical relevance of immune parameters in the tumor microenvironment of head and neck cancers. Head Neck 37(3):449–459. https://doi.org/10.1002/hed.23736

    Article  PubMed  Google Scholar 

  11. Park K, Cho KJ, Lee M, Yoon DH, Kim SB (2013) Importance of FOXP3 in prognosis and its relationship with p16 in tonsillar squamous cell carcinoma. Anticancer Res 33(12):5667–5673

    PubMed  Google Scholar 

  12. Wolf GT, Chepeha DB, Bellile E, Nguyen A, Thomas D, McHugh J University of Michigan H, neck SP (2015) tumor infiltrating lymphocytes (TIL) and prognosis in oral cavity squamous carcinoma: a preliminary study. Oral Oncol 51(1):90–95. https://doi.org/10.1016/j.oraloncology.2014.09.006

  13. de Ruiter EJ, Ooft ML, Devriese LA, Willems SM (2017) The prognostic role of tumor infiltrating T-lymphocytes in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis. Oncoimmunology 6(11):e1356148. https://doi.org/10.1080/2162402X.2017.1356148

    Article  PubMed  PubMed Central  Google Scholar 

  14. Nguyen N, Bellile E, Thomas D, McHugh J, Rozek L, Virani S, Peterson L, Carey TE, Walline H, Moyer J, Spector M, Perim D, Prince M, McLean S, Bradford CR, Taylor JM, Wolf GT, Head NSPI (2016) Tumor infiltrating lymphocytes and survival in patients with head and neck squamous cell carcinoma. Head Neck 38(7):1074–1084. https://doi.org/10.1002/hed.24406

    Article  PubMed  PubMed Central  Google Scholar 

  15. Wansom D, Light E, Thomas D, Worden F, Prince M, Urba S, Chepeha D, Kumar B, Cordell K, Eisbruch A, Taylor J, Moyer J, Bradford C, D'Silva N, Carey T, McHugh J, Wolf G, Program UMHNS (2012) Infiltrating lymphocytes and human papillomavirus-16--associated oropharyngeal cancer. Laryngoscope 122(1):121–127. https://doi.org/10.1002/lary.22133

    Article  PubMed  PubMed Central  Google Scholar 

  16. Sun DS, Zhao MQ, Xia M, Li L, Jiang YH (2012) The correlation between tumor-infiltrating Foxp3+ regulatory T cells and cyclooxygenase-2 expression and their association with recurrence in resected head and neck cancers. Med Oncol 29(2):707–713. https://doi.org/10.1007/s12032-011-9903-2

    Article  CAS  PubMed  Google Scholar 

  17. Matsutani S, Shibutani M, Maeda K, Nagahara H, Fukuoka T, Iseki Y, Kashiwagi S, Tanaka H, Hirakawa K, Ohira M (2018) Tumor-infiltrating immune cells in H&E-stained sections of colorectal Cancer tissue as a reasonable immunological biomarker. Anticancer Res 38(12):6721–6727. https://doi.org/10.21873/anticanres.13041

    Article  PubMed  Google Scholar 

  18. Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G, Wienert S, Van den Eynden G, Baehner FL, Penault-Llorca F, Perez EA, Thompson EA, Symmans WF, Richardson AL, Brock J, Criscitiello C, Bailey H, Ignatiadis M, Floris G, Sparano J, Kos Z, Nielsen T, Rimm DL, Allison KH, Reis-Filho JS, Loibl S, Sotiriou C, Viale G, Badve S, Adams S, Willard-Gallo K, Loi S, International TWG (2015) The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs working group 2014. Ann Oncol 26 (2):259–271. doi:https://doi.org/10.1093/annonc/mdu450

  19. Kushwah R, Hu J (2011) Role of dendritic cells in the induction of regulatory T cells. Cell Biosci 1(1):20. https://doi.org/10.1186/2045-3701-1-20

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Ng JH, Iyer NG, Tan MH, Edgren G (2017) Changing epidemiology of oral squamous cell carcinoma of the tongue: a global study. Head Neck 39(2):297–304. https://doi.org/10.1002/hed.24589

    Article  PubMed  Google Scholar 

  21. Almangush A, Bello IO, Coletta RD, Makitie AA, Makinen LK, Kauppila JH, Pukkila M, Hagstrom J, Laranne J, Soini Y, Kosma VM, Koivunen P, Kelner N, Kowalski LP, Grenman R, Leivo I, Laara E, Salo T (2015) For early-stage oral tongue cancer, depth of invasion and worst pattern of invasion are the strongest pathological predictors for locoregional recurrence and mortality. Virchows Arch 467(1):39–46. https://doi.org/10.1007/s00428-015-1758-z

    Article  PubMed  Google Scholar 

  22. Sopka DM, Li T, Lango MN, Mehra R, Liu JC, Burtness B, Flieder DB, Ridge JA, Galloway TJ (2013) Dysplasia at the margin? Investigating the case for subsequent therapy in 'low-risk' squamous cell carcinoma of the oral tongue. Oral Oncol 49(11):1083–1087. https://doi.org/10.1016/j.oraloncology.2013.08.001

    Article  PubMed  PubMed Central  Google Scholar 

  23. Lundqvist L, Stenlund H, Laurell G, Nylander K (2012) The importance of stromal inflammation in squamous cell carcinoma of the tongue. J Oral Pathol Med 41(5):379–383. https://doi.org/10.1111/j.1600-0714.2011.01107.x

    Article  PubMed  Google Scholar 

  24. Chatzistamou I, Rodriguez J, Jouffroy T, Girod A, Point D, Sklavounou A, Kittas C, Sastre-Garau X, Klijanienko J (2010) Prognostic significance of tumor shape and stromal chronic inflammatory infiltration in squamous cell carcinomas of the oral tongue. J Oral Pathol Med 39(9):667–671. https://doi.org/10.1111/j.1600-0714.2010.00911.x

    Article  PubMed  Google Scholar 

  25. Rodrigues PC, Miguel MC, Bagordakis E, Fonseca FP, de Aquino SN, Santos-Silva AR, Lopes MA, Graner E, Salo T, Kowalski LP, Coletta RD (2014) Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases. Int J Oral Maxillofac Surg 43(7):795–801. https://doi.org/10.1016/j.ijom.2014.01.014

    Article  CAS  PubMed  Google Scholar 

  26. Almangush A, Bello IO, Keski-Santti H, Makinen LK, Kauppila JH, Pukkila M, Hagstrom J, Laranne J, Tommola S, Nieminen O, Soini Y, Kosma VM, Koivunen P, Grenman R, Leivo I, Salo T (2014) Depth of invasion, tumor budding, and worst pattern of invasion: prognostic indicators in early-stage oral tongue cancer. Head Neck 36(6):811–818. https://doi.org/10.1002/hed.23380

    Article  PubMed  Google Scholar 

  27. Gomes JO, de Vasconcelos Carvalho M, Fonseca FP, Gondak RO, Lopes MA, Vargas PA (2016) CD1a+ and CD83+ Langerhans cells are reduced in lower lip squamous cell carcinoma. J Oral Pathol Med 45(6):433–439. https://doi.org/10.1111/jop.12389

    Article  CAS  PubMed  Google Scholar 

  28. Yilmaz T, Gedikoglu G, Celik A, Onerci M, Turan E (2005) Prognostic significance of Langerhans cell infiltration in cancer of the larynx. Otolaryngol Head Neck Surg 132(2):309–316. https://doi.org/10.1016/j.otohns.2004.04.018

    Article  PubMed  Google Scholar 

  29. Jardim JF, Gondak R, Galvis MM, Pinto CAL, Kowalski LP (2018) A decreased peritumoral CD1a+ cell number predicts a worse prognosis in oral squamous cell carcinoma. Histopathology 72(6):905–913. https://doi.org/10.1111/his.13415

    Article  PubMed  Google Scholar 

  30. Balermpas P, Michel Y, Wagenblast J, Seitz O, Weiss C, Rodel F, Rodel C, Fokas E (2014) Tumour-infiltrating lymphocytes predict response to definitive chemoradiotherapy in head and neck cancer. Br J Cancer 110(2):501–509. https://doi.org/10.1038/bjc.2013.640

    Article  CAS  PubMed  Google Scholar 

  31. Badoual C, Hans S, Rodriguez J, Peyrard S, Klein C, Agueznay Nel H, Mosseri V, Laccourreye O, Bruneval P, Fridman WH, Brasnu DF, Tartour E (2006) Prognostic value of tumor-infiltrating CD4+ T-cell subpopulations in head and neck cancers. Clin Cancer Res 12(2):465–472. https://doi.org/10.1158/1078-0432.CCR-05-1886

    Article  CAS  PubMed  Google Scholar 

  32. Watanabe Y, Katou F, Ohtani H, Nakayama T, Yoshie O, Hashimoto K (2010) Tumor-infiltrating lymphocytes, particularly the balance between CD8(+) T cells and CCR4(+) regulatory T cells, affect the survival of patients with oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 109(5):744–752. https://doi.org/10.1016/j.tripleo.2009.12.015

    Article  PubMed  Google Scholar 

  33. Chen WY, Wu CT, Wang CW, Lan KH, Liang HK, Huang BS, Chang YL, Kuo SH, Cheng AL (2018) Prognostic significance of tumor-infiltrating lymphocytes in patients with operable tongue cancer. Radiat Oncol 13(1):157. https://doi.org/10.1186/s13014-018-1099-6

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Nasman A, Romanitan M, Nordfors C, Grun N, Johansson H, Hammarstedt L, Marklund L, Munck-Wikland E, Dalianis T, Ramqvist T (2012) Tumor infiltrating CD8+ and Foxp3+ lymphocytes correlate to clinical outcome and human papillomavirus (HPV) status in tonsillar cancer. PLoS One 7(6):e38711. https://doi.org/10.1371/journal.pone.0038711

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW (2011) The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer 105(1):93–103. https://doi.org/10.1038/bjc.2011.189

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This work was supported by the National Natural Science Foundation of China (No. 81772880, 81702680), Nanjing Medical Science and Technique Development Foundation (No. YKK16164, QRX17083), Jiangsu Provincial Key Medical Discipline (since 2017), Nanjing Municipal Key Medical Laboratory Constructional Project Funding (Since 2016), Center of Nanjing Clinical Medicine of tumor project (Since 2014).

Author information

Author notes

  1. Yan-Hong Ni and Xiao-xin Zhang contributed equally to this work.

Authors and Affiliations

  1. Central Laboratory, Nanjing Stomatological Hospital, Medical School, Nanjing University, Nanjing, China

    Yan-Hong Ni, Xiao-xin Zhang, Xiao-Feng Huang, Yan Yang, Ying-chun Dong, Yue Jing, Yuxian Song, Ya-Yi Hou, Zi-chun Hua & Qin-Gang Hu

  2. Department of Oral and Maxillofacial Surgery, Nanjing Stomatological Hospital, Medical School, Nanjing University, Nanjing, China

    Yan-Hong Ni, Zhan-yi Lu, Zhi-Yong Wang & Qin-Gang Hu

  3. Nanjing, China

    Qin-Gang Hu

Authors
  1. Yan-Hong Ni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiao-xin Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zhan-yi Lu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Xiao-Feng Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Zhi-Yong Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yan Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Ying-chun Dong
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Yue Jing
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Yuxian Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Ya-Yi Hou
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Zi-chun Hua
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Qin-Gang Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Conflict of Interest

None declared.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

ESM 1

(DOCX 1700 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ni, YH., Zhang, Xx., Lu, Zy. et al. Tumor-Infiltrating CD1a+ DCs and CD8+/FoxP3+ Ratios Served as Predictors for Clinical Outcomes in Tongue Squamous Cell Carcinoma Patients. Pathol. Oncol. Res. 26, 1687–1695 (2020). https://doi.org/10.1007/s12253-019-00701-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12253-019-00701-5

Keywords

Search

Navigation